Docetaxel/unspecified platinum complexes
- PDF / 169,238 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 83 Downloads / 188 Views
1 S
Docetaxel/unspecified platinum complexes Oesophageal fistula: case report
In a retrospective study of 89 patients who had locally advanced stage III non-small-cell lung cancer (NSCLC) treated with concurrent radiochemotherapy at a cancer centre in France between 2005 and 2014, a man [age not stated] was described, who died due to oesophageal fistula following chemotherapy with docetaxel and unspecified platinum-complexes for NSCLC. The man, who had locally advanced stage III NSCLC with oesophageal involvement, started receiving IV injection of docetaxel weekly and IV injection of unspecified platinum-complexes weekly [platinum-based drug; doses not stated]. Concurrently, he received thoracic radiotherapy. Following the end of concurrent treatment, he died due to grade V oesophageal fistula [time to reaction onset not stated]. Kaderbhai C-G, et al. Outcomes of concurrent radiotherapy with weekly docetaxel and platinum-based chemotherapy in stage III non-small-cell lung cancer. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 24: 279-287, No. 4, Jul 2020. Available from: URL: http://doi.org/10.1016/ j.canrad.2019.09.009
0114-9954/20/1824-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
803504665
Reactions 3 Oct 2020 No. 1824
Data Loading...
